These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31705038)

  • 1. Neural oscillations during cognitive processes in an App knock-in mouse model of Alzheimer's disease pathology.
    Jacob S; Davies G; De Bock M; Hermans B; Wintmolders C; Bottelbergs A; Borgers M; Theunis C; Van Broeck B; Manyakov NV; Balschun D; Drinkenburg WHIM
    Sci Rep; 2019 Nov; 9(1):16363. PubMed ID: 31705038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in open field activity in the absence of memory deficits in the App
    Whyte LS; Hemsley KM; Lau AA; Hassiotis S; Saito T; Saido TC; Hopwood JJ; Sargeant TJ
    Behav Brain Res; 2018 Jan; 336():177-181. PubMed ID: 28887197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtle behavioral changes and increased prefrontal-hippocampal network synchronicity in APP
    Latif-Hernandez A; Shah D; Craessaerts K; Saido T; Saito T; De Strooper B; Van der Linden A; D'Hooge R
    Behav Brain Res; 2019 May; 364():431-441. PubMed ID: 29158112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia.
    Benitez DP; Jiang S; Wood J; Wang R; Hall CM; Peerboom C; Wong N; Stringer KM; Vitanova KS; Smith VC; Joshi D; Saito T; Saido TC; Hardy J; Hanrieder J; De Strooper B; Salih DA; Tripathi T; Edwards FA; Cummings DM
    Mol Neurodegener; 2021 Jul; 16(1):47. PubMed ID: 34266459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the App
    Arroyo-García LE; Isla AG; Andrade-Talavera Y; Balleza-Tapia H; Loera-Valencia R; Alvarez-Jimenez L; Pizzirusso G; Tambaro S; Nilsson P; Fisahn A
    Mol Psychiatry; 2021 Oct; 26(10):5557-5567. PubMed ID: 34385602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Touchscreen-based location discrimination and paired associate learning tasks detect cognitive impairment at an early stage in an App knock-in mouse model of Alzheimer's disease.
    Saifullah MAB; Komine O; Dong Y; Fukumoto K; Sobue A; Endo F; Saito T; Saido TC; Yamanaka K; Mizoguchi H
    Mol Brain; 2020 Nov; 13(1):147. PubMed ID: 33183323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer's disease.
    Armstrong P; Güngör H; Anongjanya P; Tweedy C; Parkin E; Johnston J; Carr IM; Dawson N; Clapcote SJ
    Neuropsychopharmacology; 2024 Sep; 49(10):1559-1568. PubMed ID: 38521860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent behavioral and biochemical characterization of single APP knock-in mouse (APP
    Mehla J; Lacoursiere SG; Lapointe V; McNaughton BL; Sutherland RJ; McDonald RJ; Mohajerani MH
    Neurobiol Aging; 2019 Mar; 75():25-37. PubMed ID: 30508733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological and neurophysiological outcomes of seeding human-derived tau pathology in the APP-KI NL-G-F and NL-NL mouse models of Alzheimer's Disease.
    Tok S; Maurin H; Delay C; Crauwels D; Manyakov NV; Van Der Elst W; Moechars D; Drinkenburg WHIM
    Acta Neuropathol Commun; 2022 Jun; 10(1):92. PubMed ID: 35739575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic nSMase inhibition suppresses neuronal exosome spreading and sex-specifically attenuates amyloid pathology in APP knock-in Alzheimer's disease mice.
    Mowry FE; Espejo-Porras F; Jin S; Quadri Z; Wu L; Bertolio M; Jarvis R; Reynolds C; Alananzeh R; Bieberich E; Yang Y
    Neurobiol Dis; 2023 Aug; 184():106213. PubMed ID: 37364689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid β peptide.
    Sato K; Watamura N; Fujioka R; Mihira N; Sekiguchi M; Nagata K; Ohshima T; Saito T; Saido TC; Sasaguri H
    J Biol Chem; 2021 Sep; 297(3):101004. PubMed ID: 34329683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An App knock-in mouse inducing the formation of a toxic conformer of Aβ as a model for evaluating only oligomer-induced cognitive decline in Alzheimer's disease.
    Izuo N; Murakami K; Fujihara Y; Maeda M; Saito T; Saido TC; Irie K; Shimizu T
    Biochem Biophys Res Commun; 2019 Jul; 515(3):462-467. PubMed ID: 31164199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in Tau Pathology in P290S
    Huang M; Macdonald J; Lavenir I; Chen R; Craxton M; Slavik-Smith E; Davies SW; Goedert M
    eNeuro; 2022; 9(6):. PubMed ID: 36635241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dramatic impacts on brain pathology, anxiety, and cognitive function in the knock-in APP
    Mehla J; Deibel SH; Karem H; Hossain S; Lacoursiere SG; Sutherland RJ; Mohajerani MH; McDonald RJ
    Alzheimers Res Ther; 2022 Sep; 14(1):143. PubMed ID: 36180883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.
    Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE
    Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau.
    Guo Q; Li H; Cole AL; Hur JY; Li Y; Zheng H
    PLoS One; 2013; 8(11):e80706. PubMed ID: 24278307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein
    Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z
    Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Hyperhomocysteinemia and Different Dietary Interventions on Cognitive Performance in a Knock-in Mouse Model for Alzheimer's Disease.
    Nieraad H; de Bruin N; Arne O; Hofmann MCJ; Schmidt M; Saito T; Saido TC; Gurke R; Schmidt D; Till U; Parnham MJ; Geisslinger G
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.